These results indirectly indicate that the decrease in miR-122 expression caused by maternal HFD might regulate the increase in AGPAT1 and SCD1 mRNA and the decrease in HMGCR mRNA in HFD-O mice, leading to lipid metabolism disorders. The gene discussed is AGPAT1; the disease is Disorder of lipid metabolism.